Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Battella

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Leukocyte Biology|July 3, 2015
Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactionsSimone Battella, Maria Christina Cox, Angela Santoni, et al.
Journal of Immunology Research|March 19, 2019
Memory NK Cell Features Exploitable in Anticancer ImmunotherapyCristina Capuano, Chiara Pighi, Simone Battella, et al.
Cancers|June 2, 2021
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbsCristina Capuano, Chiara Pighi, Simone Battella, et al.
Journal of Leukocyte Biology|August 28, 2015
Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiationGiorgio Camilli, Antonino Cassotta, Simone Battella, et al.
Frontiers in Immunology|June 6, 2018
Tumor-Targeting Anti-CD20 Antibodies Mediate <i>In Vitro</i> Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and <i>In Vivo</i> PrimingCristina Capuano, Simone Battella, Chiara Pighi, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2020
CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γ<sub>c</sub> cytokine stimulation via PI3K/mTOR axisCristina Capuano, Chiara Pighi, Roberta Maggio, et al.
Cytotherapy|December 27, 2015
T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cellsMaria Michela D'Aloia, Sara Caratelli, Camilla Palumbo, et al.
Oncoimmunology|April 14, 2017
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ productionCristina Capuano, Chiara Pighi, Rosa Molfetta, et al.
Biomedicines|March 25, 2022
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and CompositionCristina Capuano, Chiara Pighi, Simone Battella, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2017
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapySimone Battella, M Christina Cox, Raffaella La Scaleia, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Leukocyte Biology|July 3, 2015
Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactionsSimone Battella, Maria Christina Cox, Angela Santoni, et al.
Journal of Immunology Research|March 19, 2019
Memory NK Cell Features Exploitable in Anticancer ImmunotherapyCristina Capuano, Chiara Pighi, Simone Battella, et al.
Cancers|June 2, 2021
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbsCristina Capuano, Chiara Pighi, Simone Battella, et al.
Journal of Leukocyte Biology|August 28, 2015
Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiationGiorgio Camilli, Antonino Cassotta, Simone Battella, et al.
Frontiers in Immunology|June 6, 2018
Tumor-Targeting Anti-CD20 Antibodies Mediate <i>In Vitro</i> Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and <i>In Vivo</i> PrimingCristina Capuano, Simone Battella, Chiara Pighi, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2020
CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γ<sub>c</sub> cytokine stimulation via PI3K/mTOR axisCristina Capuano, Chiara Pighi, Roberta Maggio, et al.
Cytotherapy|December 27, 2015
T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cellsMaria Michela D'Aloia, Sara Caratelli, Camilla Palumbo, et al.
Oncoimmunology|April 14, 2017
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ productionCristina Capuano, Chiara Pighi, Rosa Molfetta, et al.
Biomedicines|March 25, 2022
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and CompositionCristina Capuano, Chiara Pighi, Simone Battella, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2017
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapySimone Battella, M Christina Cox, Raffaella La Scaleia, et al.
Pageof 3